Patent 11781156 was granted and assigned to Tenaya Therapeutics on October, 2023 by the United States Patent and Trademark Office.
Provided herein are methods and compositions for plakophilin-2 gene therapy for treating heart diseases such as arrhythmogenic right ventricular cardiomyopathy (ARVC) or arrhythmogenic cardiomyopathy (ACM).